Literature DB >> 19880140

Regional changes in bone area and bone mineral content in boys with duchenne muscular dystrophy receiving corticosteroid therapy.

Nicola J Crabtree1, Helen Roper, Heather McMurchie, Nicholas J Shaw.   

Abstract

OBJECTIVE: To examine the functional and skeletal effects of 30 months of steroid treatment in boys with Duchenne muscular dystrophy. STUDY
DESIGN: Lumbar spine (L(2)L(4)) and subcranial dual energy X-ray absorptiometry scanning was performed on 25 boys (mean age 7.4 years) at baseline and after 30 months of steroid treatment.
RESULTS: At baseline, L(2)L(4) bone mineral content (BMC) was significantly low for projected bone area although appropriate for reduced lean body mass (LBM). Subcranial bone area for height and subcranial BMC for area and LBM were all significantly reduced. After 30 months of steroid therapy there was a significant increase in subcranial bone area for height but a significant reduction of subcranial BMC for area. At the lumbar spine there were no significant changes in bone area but small increases in L(2)L(4) BMC both for bone area and LBM.
CONCLUSION: At baseline reduced mechanical load from diminished muscle function results in narrow light bones more noticeable in the subcranial region than the lumbar spine. Increases observed in subcranial bone area at 30 months suggest a gradual adaptation to increased gravitational load whereas at the spine there were no apparent detrimental effects on bone after 30 months of steroid therapy. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880140     DOI: 10.1016/j.jpeds.2009.09.010

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Insights into bone health in Duchenne muscular dystrophy.

Authors:  Victor H Morgenroth; Lauren P Hache; Paula R Clemens
Journal:  Bonekey Rep       Date:  2012-02-01

Review 2.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Authors:  Jennifer M Bell; Michael D Shields; Janet Watters; Alistair Hamilton; Timothy Beringer; Mark Elliott; Rosaline Quinlivan; Sandya Tirupathi; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

3.  Articular cartilage degeneration and bone adaptation due to lack of dystrophin in mice.

Authors:  José Fontes Dos Santos; Mariana Cruz Lazzarin; Vivianne Izabelle de Araújo Baptista; Hananiah Tardivo Quintana; Daniel Araki Ribeiro; Flavia de Oliveira
Journal:  J Bone Miner Metab       Date:  2021-09-22       Impact factor: 2.626

4.  Bone Health and Endocrine Care of Boys with Duchenne Muscular Dystrophy: Data from the MD STARnet.

Authors:  David R Weber; Shiny Thomas; Stephen W Erickson; Deborah Fox; Joyce Oleszek; Shree Pandya; Yedatore Venkatesh; Christina Westfield; Emma Ciafaloni
Journal:  J Neuromuscul Dis       Date:  2018

5.  Black bear parathyroid hormone has greater anabolic effects on trabecular bone in dystrophin-deficient mice than in wild type mice.

Authors:  Sarah K Gray; Meghan E McGee-Lawrence; Jennifer L Sanders; Keith W Condon; Chung-Jui Tsai; Seth W Donahue
Journal:  Bone       Date:  2012-05-11       Impact factor: 4.398

6.  Bone Density in the Obese Child: Clinical Considerations and Diagnostic Challenges.

Authors:  Jennifer C Kelley; Nicola Crabtree; Babette S Zemel
Journal:  Calcif Tissue Int       Date:  2017-01-20       Impact factor: 4.333

7.  Gastrocnemius medialis muscle architecture and physiological cross sectional area in adult males with Duchenne muscular dystrophy.

Authors:  C I Morse; J Smith; A Denny; J Tweedale; N D Searle
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

8.  Bone health measured using quantitative ultrasonography in adult males with muscular dystrophy.

Authors:  C I Morse; J Smith; A Denny; J Tweedale; N D Searle; K Winwood; G L Onambele-Pearson
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-12-14       Impact factor: 2.041

9.  Bone Mineral Density Assessment by Quantitative Computed Tomography in Glucocorticoid-Treated Boys With Duchenne Muscular Dystrophy: A Linear Mixed-Effects Modeling Approach.

Authors:  Chuan Liu; Dan-Dan Yang; Lu Zhang; Xian-Gao Lei; Feng-Lin Jia; Yi Liao; Xi-Jian Chen; Gang Ning; Wen Luo; Hai-Bo Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-23       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.